Radiotherapy firm Accuray announced that its CyberKnife robotic radiosurgery system has been used for the first time in extracranial treatments of patients in Japan.
The Sunnyvale, CA-based firm markets the system as CyberKnife II in Japan. In June 2008, Japan's Ministry of Health, Labor, and Welfare granted approval to use CyberKnife for extracranial treatment, including tumors in the spine, lung, liver, pancreas, and prostate. CyberKnife was previously approved in Japan only for intracranial, head, and neck tumors.
Japan has the second largest installed base of Accuray's CyberKnife systems, the company said.
Related Reading
Accuray grows revenue in Q2, January 30, 2009
Accuray notches 100th U.S. installation, December 24, 2008
NY Times: CyberKnife Medicare coverage varies in U.S., December 23, 2008
Accuray posts mixed Q1 results, December 19, 2008
Accuray reaches milestone, December 9, 2008
Copyright © 2009 AuntMinnie.com
